Young Cannabis Consumers with Mood Disorders at Higher Risk of Self-Harm, Study Finds
As the study was purely observational, the researchers do not suggest any type of causality or mechanism behind these associations. But they do recommend further studies to help inform policy and treatment decisions.
Cannabis Use Rises Through the Calendar Year, But Dips for Dry January, Study Finds
Researchers from New York University found that relative usage rates of cannabis were up 13 percent at the end of each year compared to the first quarter.
NIST’s Cannabis Testing Program Enters Second Phase, Seeks New Labs
The federal study aims to improve the testing standards used throughout the cannabis lab sector. Any lab interested in participating in the next phase of the project has until February 5 to enroll.
USDA Releases Final Rules on Hemp, Effective From March 22
In a win for hemp farmers, the final rule widens the margin of error for THC levels in hemp plants before a cultivator is declared criminally negligent. However, several high-profile sticking points remain, including some guidelines on sampling.
ProVerde’s Maine Cannbis Lab Shut Down For Unlicensed Testing
Responding to Analytical Cannabis, ProVerde president Chris Hudalla explained that the Maine lab was “in operation before there were any requirements or mechanisms for licensing of marijuana testing laboratories in Maine.”
What a Democrat-led Senate Means for Cannabis Legalization
Does Democratic control of both houses of Congress mean legalization is around the corner?
Colorado Regulators Recall Cannabis Products Due to Mold Contamination
Any consumer in possession of such a product has been advised by the Colorado Department of Revenue to return it to the initial retailer.
UK Regulator Grants Second Commercial License to Grow Medical Cannabis
The Jersey-based company has become the second cultivator in the British Isles to be licensed by the UK Home Office to grow pharmaceutical-grade cannabis for profit.
FDA Outlines Plan to Improve CBD Research Data
The administration said it intends to use poison control records and other databases to better identify CBD products associated with adverse events. A new opt-in registry for CBD consumers is also in the works.
